{"filing":{"accession_number":"0001213900-26-112193","cik":"0001839285","ticker":"HCTI","company_name":"Healthcare Triangle, Inc.","form":"8-K","filing_date":"2026-10-23","report_date":"2026-10-23","primary_document":"ea0309560-8k_healthcare.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026112193/ea0309560-8k_healthcare.htm"},"events":[{"id":37711,"run_id":34751,"accession_number":"0001213900-26-112193","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder vote results from a special meeting held on October 23, 2026, presenting final voting tallies on four proposals: approval of reverse stock splits (1:2 to 1:25 ratio), approval of a 20% issuance under Nasdaq Rule 5635(d), amendment to the 2020 Stock Incentive Plan, and adjournment authority. All four proposals passed with overwhelming majorities. The reverse split and dilutive issuance approvals are material to investors' assessment of capital structure and ownership dilution risk.","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-10-23","form":"8-K","submitted_at":null,"items":[{"id":42505,"accession_number":"0001213900-26-112193","item_number":"5.07","item_title":"Submission of Matters to a Vote","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a special meeting held on October 23, 2026, presenting final voting tallies on four proposals: approval of reverse stock splits (1:2 to 1:25 ratio), approval of a 20% issuance under Nasdaq Rule 5635(d), amendment to the 2020 Stock Incentive Plan, and adjournment authority. All four proposals passed with overwhelming majorities. The reverse split and dilutive issuance approvals are material to investors' assessment of capital structure and ownership dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T21:22:58.197651+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42505,"accession_number":"0001213900-26-112193","item_number":"5.07","item_title":"Submission of Matters to a Vote","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a special meeting held on October 23, 2026, presenting final voting tallies on four proposals: approval of reverse stock splits (1:2 to 1:25 ratio), approval of a 20% issuance under Nasdaq Rule 5635(d), amendment to the 2020 Stock Incentive Plan, and adjournment authority. All four proposals passed with overwhelming majorities. The reverse split and dilutive issuance approvals are material to investors' assessment of capital structure and ownership dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T21:22:58.197651+00:00","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-10-23"}]}